Sionna Therapeutics

Developing small molecule medicines to treat cystic fibrosis.

BiotechnologyPharmaceuticals sionnatx.com ↗

Company facts

Founded
2019
Employees
63
Headquarters
United States
Type
Public
Listed
NASDAQ: SION
Subsidiaries
Sionna Therapeutics Securities Corporation